dc.date.accessioned2019-12-06T21:02:58Z
dc.date.available2019-12-06T21:02:58Z
dc.date.created2019-12-06T21:02:58Z
dc.date.issued2019
dc.identifierhttps://hdl.handle.net/20.500.12866/7524
dc.identifierhttps://doi.org/10.1007/s11926-019-0851-8
dc.description.abstractPURPOSE OF THE REVIEW: Most of the primary vasculitis in children and adults has different clinical manifestations for the same disease, which suggests that they might not be part of the same clinical spectrum and requires a different approach in order to reduce the morbidity and mortality of these patients. In this work, we review the most recent literature and the most important studies that describe and compare adult and children primary vasculitides pathogenesis, clinical presentation, and treatment approach. Accordingly, we discuss recent research involving clinical trials, comparison studies, and pathogeny for these vasculitides. RECENT FINDINGS: Clinical manifestations in the different primary vasculitis change in predominance from adults to children. There is a female sex predominance for the ANCA vasculitides in children compared with adults, but the same treatment works in most cases for both groups. Identifying the diverse clinical spectrum in both adults and children primary vasculitides will reduce the need to extrapolate the diagnostic criteria from one group to another and individualize it, which will allow the clinician to establish a better approach.
dc.languageeng
dc.publisherSpringer
dc.relationCurrent Rheumatology Reports
dc.relation1534-6307
dc.rightshttps://creativecommons.org/licenses/by-nc-nd/4.0/deed.es
dc.rightsinfo:eu-repo/semantics/restrictedAccess
dc.subjectanaphylactoid purpura
dc.subjectANCA associated vasculitis
dc.subjectaortic arch syndrome
dc.subjectclinical feature
dc.subjectcomparative study
dc.subjectcorticosteroid
dc.subjectcyclophosphamide
dc.subjectdisease classification
dc.subjectdisease modifying antirheumatic drug
dc.subjecteosinophilic granuloma
dc.subjecteosinophilic granulomatosis with polyangiitis
dc.subjectgender
dc.subjectgiant cell arteritis
dc.subjectglucocorticoid
dc.subjecthuman
dc.subjectimmunoglobulin
dc.subjectimmunosuppressive treatment
dc.subjectincidence
dc.subjectmethotrexate
dc.subjectmicroscopic polyangiitis
dc.subjectmolecular pathology
dc.subjectmucocutaneous lymph node syndrome
dc.subjectonset age
dc.subjectpathogenesis
dc.subjectPathogenesis
dc.subjectpatient care
dc.subjectPediatric vasculitides
dc.subjectpolyarteritis nodosa
dc.subjectPrimary vasculitides
dc.subjectremission
dc.subjectReview
dc.subjectSystemic vasculitis
dc.subjectTreatment
dc.subjectvasculitis
dc.subjectWegener granulomatosis
dc.titleChildhood- Versus Adult-Onset Primary Vasculitides: Are They Part of the Same Clinical Spectrum?
dc.typeinfo:eu-repo/semantics/article


Este ítem pertenece a la siguiente institución